Skip to main content
main-content

Amar Puttanna

Amar Puttanna, MBChB MRCP (UK) MRCP Diabetes and Endocrinology, is a Diabetes Consultant in the West Midlands, having graduated from the University of Birmingham. He is particularly interested in education, having won multiple teaching awards from the University of Birmingham and the Royal College of Physicians of Edinburgh and previously been on the Royal College (MRCP) Part 1 examining board. In 2018 he won the RCP Excellence in Patient Care Award for outstanding contribution to the profession.

Dr. Puttanna is a former chair of the Young Diabetologists and Endocrinologists Forum (YDEF), a national registrar organisation aimed at developing and representing the specialty and its trainees. He works closely with the Royal College of Physicians and was one of the first Chief Registrars, a unique role aimed at developing leadership and management skills in senior trainees. He is published regularly and taken part in consensus discussions regarding diabetes management. He is also involved in writing national guidelines, specifically on older adults with diabetes.

Dr. Puttanna's interests are in cardiovascular disease, novel medications for patients with diabetes, diabetes management in the older adult; specifically cognitive impairment via his DIADEM project which won the Quality in Care (QiC) Diabetes Awards 2018. He regularly delivers talks to a wide variety of audiences from students to general practitioners as well as secondary care teams and has presented his work at various national and international meetings.

Latest contributions from Amar Puttanna

03-07-2019 | Diet | Video | Article

Clinical takeaways: The DiRECT trial

Amar Puttanna highlights the key clinical messages that have come out of the DiRECT trial (0:59).

03-04-2019 | Mental health | Editorial | Article

Diabetes and dementia: Addressing the needs of an overlooked population

Diabetologist Amar Puttanna addresses growing concerns about the rise of dementia in diabetes care and highlights where guidelines, research efforts, and management options are needed to tackle this comorbidity.

02-13-2018 | Older adults | Editorial | Article

Does setting treatment targets risk the overtreatment of type 2 diabetes in older patients?

The drive to achieve lower HbA1c targets in older patients is not without concern or risk. Our UK Board address concerns highlighted by recent trials and discuss whether current guidelines do enough to mitigate the risks of overtreatment.

Image Credits